XML 80 R15.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CSC HOLDINGS - CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2019
Mar. 31, 2019
Dec. 31, 2018
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:                  
Net income $ 1,331,000 $ (25,198,000) $ 213,808,000 $ (128,949,000)   $ 139,939,000 $ 20,594,000 $ 1,494,764,000  
Adjustments to reconcile net income to net cash provided by (used in) operating activities:                  
Depreciation, Depletion and Amortization           2,263,144,000 2,382,339,000 2,930,571,000  
Equity in net loss of affiliates           0 10,849,000 10,040,000  
Gain (Loss) on Investments And Sale Of Affiliated Interests           (473,406,000) 250,877,000 (237,354,000)  
Loss (gain) on equity derivative contracts, net           282,713,000 (218,848,000) 236,330,000  
Loss on extinguishment of debt and write-off of deferred financing costs           243,806,000 48,804,000 600,240,000  
Amortization of deferred financing costs and discounts (premiums) on indebtedness           106,214,000 85,121,000 31,046,000  
Share-based compensation expense related to equity classified awards           99,078,000 59,812,000 57,430,000  
Deferred income taxes           14,931,000 (67,603,000) (2,880,154,000)  
Provision for doubtful accounts           91,520,000 71,426,000 74,183,000  
Change in assets and liabilities, net of effects of acquisitions and dispositions:                  
Accounts receivable, trade           (91,718,000) (144,079,000) (89,683,000)  
Other receivables           (21,755,000) 4,246,000 (12,835,000)  
Prepaid expenses and other assets           (100,343,000) (14,889,000) (7,426,000)  
Amounts due from and due to affiliates           (7,857,000) 11,049,000 (34,326,000)  
Accounts payable           (33,107,000) 12,455,000 73,888,000  
Accrued liabilities           (44,083,000) (130,631,000) (241,701,000)  
Deferred revenue           (10,384,000) 72,426,000 12,310,000  
Liabilities related to interest rate swap and derivative contracts           30,338,000 53,101,000 (921,000)  
Net cash provided by operating activities           2,554,169,000 2,508,317,000 2,018,247,000  
Cash flows from investing activities:                  
Capital expenditures           (1,355,350,000) (1,153,589,000) (951,349,000)  
Payment for acquisitions, net of cash acquired           (172,269,000) (10,753,000) (46,703,000)  
Sale of affiliate interest           1,958,000   0  
Sale of affiliate interest             3,537,000    
Proceeds related to sale of equipment, including costs of disposal           3,909,000 10,779,000 9,743,000  
Decrease (increase) in other investments           354,000 9,327,000 (4,773,000)  
Settlement of put call options           0 0 97,410,000  
Additions to other intangible assets           (4,071,000) (584,000) (1,707,000)  
Net cash used in investing activities           (1,525,469,000) (1,148,357,000) (1,092,199,000)  
Cash flows from financing activities:                  
Proceeds from credit facility debt, net of discounts           5,040,000,000 3,489,313,000 5,593,675,000  
Repayment of credit facility debt           (3,832,062,000) (2,221,175,000) (4,411,581,000)  
Proceeds from issuance of senior notes           4,054,375,000 2,050,000,000 0  
Redemption of senior notes, including premiums and fees           (4,225,786,000) (2,628,962,000) (1,729,400,000)  
Proceeds from collateralized indebtedness           93,000,000 516,513,000 838,794,000  
Repayment of collateralized indebtedness and related derivative contracts, net           0 (516,513,000) (831,059,000)  
Payments of dividends         $ 79,617,000 0 1,499,935,000 919,317,000 $ 365,559,000
Proceeds from Contributed Capital           0 0 1,135,000  
Proceeds from notes payable           65,854,000 15,955,000 33,733,000  
Repayment of notes payable           (102,066,000) (32,632,000) 0  
Principal payments on finance lease obligations           (8,980,000) (10,228,000) (15,157,000)  
Additions to deferred financing costs           (23,583,000) (28,468,000) (8,600,000)  
Contingent payment for acquisition           (500,000) (30,000,000) 0  
Proceeds from (Payments to) Noncontrolling Interests           (1,000,000) 5,995,000 (335,000)  
Net cash used in financing activities           (624,412,000) (1,390,996,000) (1,099,041,000)  
Net increase (decrease) in cash and cash equivalents           404,288,000 (31,036,000) (172,993,000)  
Effect of exchange rate changes on cash and cash equivalents           (1,166,000) (26,000) 0  
Net increase (decrease) in cash and cash equivalents           403,122,000 (31,062,000) (172,993,000)  
Cash, cash equivalents and restricted cash at beginning of year   299,038,000   330,100,000 503,093,000 299,038,000 330,100,000 503,093,000  
Cash, cash equivalents and restricted cash at end of year 702,160,000   299,038,000     702,160,000 299,038,000 330,100,000 503,093,000
Restructuring Reserve, Settled without Cash           16,826,000 0 0  
Non-cash lease expense           46,581,000 0 0  
CSC Holdings                  
Cash flows from operating activities:                  
Net income 21,022,000 (7,864,000) 242,020,000 (89,968,000)   212,817,000 260,326,000 2,577,876,000  
Adjustments to reconcile net income to net cash provided by (used in) operating activities:                  
Depreciation, Depletion and Amortization           2,263,144,000 2,382,339,000 2,930,571,000  
Equity in net loss of affiliates           0 10,849,000 10,040,000  
Gain (Loss) on Investments And Sale Of Affiliated Interests           (473,406,000) 261,536,000 (237,354,000)  
Loss (gain) on equity derivative contracts, net           282,713,000 (218,848,000) 138,920,000  
Loss on extinguishment of debt and write-off of deferred financing costs           228,130,000 7,883,000 53,988,000  
Amortization of deferred financing costs and discounts (premiums) on indebtedness           90,706,000 43,135,000 13,226,000  
Settlement loss and amortization of actuarial losses related to pension and postretirement plans           1,732,000 1,268,000 1,845,000  
Share-based compensation expense related to equity classified awards           99,078,000 59,812,000 57,430,000  
Deferred income taxes           (238,709,000) (251,593,000) (3,026,782,000)  
Provision for doubtful accounts           91,520,000 71,426,000 74,183,000  
Change in assets and liabilities, net of effects of acquisitions and dispositions:                  
Accounts receivable, trade           (91,718,000) (144,079,000) (89,683,000)  
Other receivables           (12,512,000) 4,048,000 (12,707,000)  
Prepaid expenses and other assets           (100,343,000) (27,986,000) (12,135,000)  
Amounts due from and due to affiliates           247,917,000 175,159,000 (413,930,000)  
Accounts payable           (33,107,000) 12,455,000 73,888,000  
Accrued liabilities           (27,581,000) (7,182,000) (97,154,000)  
Deferred revenue           (10,384,000) 72,426,000 20,634,000  
Liabilities related to interest rate swap and derivative contracts           30,338,000 53,101,000 (921,000)  
Net cash provided by operating activities           2,623,742,000 2,766,075,000 2,061,935,000  
Cash flows from investing activities:                  
Capital expenditures           (1,355,350,000) (1,153,589,000) (951,349,000)  
Payment for acquisitions, net of cash acquired           (172,269,000) (10,753,000) (46,703,000)  
Sale of affiliate interest           1,958,000   0  
Sale of affiliate interest             3,537,000    
Proceeds related to sale of equipment, including costs of disposal           3,909,000 10,779,000 9,743,000  
Decrease (increase) in other investments           354,000 (2,500,000) (4,773,000)  
Additions to other intangible assets           (4,071,000) (584,000) (1,707,000)  
Net cash used in investing activities           (1,525,469,000) (1,160,184,000) (994,789,000)  
Cash flows from financing activities:                  
Proceeds from credit facility debt, net of discounts           5,040,000,000 3,489,313,000 5,593,675,000  
Repayment of credit facility debt           (3,832,062,000) (2,221,175,000) (4,411,581,000)  
Proceeds from issuance of senior notes           4,054,375,000 1,000,000,000 0  
Redemption of senior notes, including premiums and fees           (3,703,454,000) (805,206,000) (350,120,000)  
Proceeds from collateralized indebtedness           93,000,000 516,513,000 838,794,000  
Repayment of collateralized indebtedness and related derivative contracts, net           0 (516,513,000) (831,059,000)  
Payments of dividends           2,279,472,000 3,058,750,000 2,777,497,000  
Proceeds from Contributed Capital           0 50,000,000 761,316,000  
Proceeds from notes payable           65,854,000 15,955,000 33,733,000  
Repayment of notes payable           (102,066,000) (32,632,000) 0  
Principal payments on finance lease obligations           (8,980,000) (10,228,000) (15,157,000)  
Additions to deferred financing costs           (23,583,000) (28,471,000) (8,171,000)  
Contingent payment for acquisition           (500,000) (30,000,000) 0  
Proceeds from (Payments to) Noncontrolling Interests           (1,000,000) 5,995,000 (335,000)  
Net cash used in financing activities           (697,888,000) (1,625,199,000) (1,166,402,000)  
Net increase (decrease) in cash and cash equivalents           400,385,000 (19,308,000) (99,256,000)  
Effect of exchange rate changes on cash and cash equivalents           (1,166,000) (26,000) 0  
Net increase (decrease) in cash and cash equivalents           399,219,000 (19,334,000) (99,256,000)  
Cash, cash equivalents and restricted cash at beginning of year   $ 298,784,000   $ 318,118,000 $ 417,374,000 298,784,000 318,118,000 417,374,000  
Cash, cash equivalents and restricted cash at end of year $ 698,003,000   $ 298,784,000     698,003,000 298,784,000 318,118,000 $ 417,374,000
Restructuring Reserve, Settled without Cash           16,826,000 0 0  
Non-cash lease expense           $ 46,581,000 $ 0 $ 0